AzTrials
AzTrials

Cleft Lip and PalateNCT05535530

The Effect of a Newly Designed Presurgical Orthopedic Appliance

A study testing Active PSIO in people with Cleft Lip and Palate, run by University of Baghdad at 1 site in Iraq.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A randomized clinical trial to compare the effectiveness of newly designed active type of presurgical orthopedic appliances on maxillary arch dimensions in infants with bilateral cleft lip and palate. Read more about this study

Who is it for?
Ages 5 days to 2 monthsHealthy volunteers can take part
Conditions the study is for
Cleft Lip and Palate
What is being tested?
Active PSIO
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteIraq
Study dates
1 Jan 2021to 1 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 days to 2 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • 1. Healthy new born infants with complete bilateral cleft lip, alveolus and palate.
  • 2. Non-syndromic. 3. Non-operated cases.

Who cannot join

  • 1. Infants with systemic syndromes. 2.Facial deformities.

Trial locations and contacts

1 site in 1 country.

Iraq1 site
  • Mushreq Abed

    Baghdad, Al-Rusafa, 01110

Other trials in Iraq

About this study

Official title: The Effect of a Newly Designed Presurgical Orthopedic Appliance on Maxillary Arch Dimensions in Infants With Bilateral Cleft Lip and Palate: Randomized Clinical Trial

A randomized clinical trial to compare the effectiveness of newly designed active type of presurgical orthopedic appliances on maxillary arch dimensions in infants with bilateral cleft lip and palate.

Read the detailed description

It is a multicenter randomized clinical trial with two parallel arms. The patients will be randomly divided into two groups, group one: a passive orthopedic appliance will be used, and group two a new designed active orthopedic appliance will be used. Impressions will be taken before starting the treatment (T1) and at the end of treatment (T2) three months later. The effectiveness of the two appliances will be assessed and measured on digital models of the maxillary arch before and after the treatment.

Being tested
Active PSIO
Keywords
Cleft lip and palate, Bilateral, Presurgical orthopaedic appliance
Medical subject headings
Cleft Lip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active PSIODevice

    new designed active orthopedic appliance will be used. Impressions will be taken before starting the treatment (T1) and at the end of treatment (T2) three months later. The effectiveness of the two appliances will be assessed and measured on digital models of the maxillary arch before and after the treatment.

Study groups in NCT05535530
Study groupRoleWhat they receive
Control groupNo interventionPassive PSIO will be used
ExperimentalExperimentalActive PSIO will be used
Receives: Device: Active PSIO

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Arch dimension (experimental group and control group)

    Evaluation of the efficiency of a newly designed presurgical infant orthopedic for bilateral cleft lip and palate patients by measuring the maxillary arch dimension at the beginning and end of treatment in both experimental and control group.

    Measured: T1 before starting any treatment and T2 After treatment before surgical repair (average 3 months)

Secondary outcomes (4)
  1. Parents Perception and experience

    The perception and experience of parents of children with cleft lip and palate concerning the use presurgical infant orthopedics using a questionnaire-based cross sectional survey. The assessment of mothers' perception and experience regarding PSIO will be executed using 16 validated preformed questions. The onset of the sign of the positive correction of the cleft segments will be recorded accordingly. In addition, PSIO management, including the removable appliance's hygiene maintenance, was also assessed.

    Measured: T1 before starting any treatment and T2 After treatment before surgical repair (average 3 months)

  2. Linear measurement (experimental group and control group)

    The linear measurements of arch dimensions in millimeter before and after treatment with the new presurgical infant orthopedic within the cleft patients in both experimental and control group.

    Linear measurements for maxillary arch assessments in millimeters:

    • Antero-posterior arch length (I-RTLT)
    • Posterior arch width (RT-LT)
    • Alveolar cleft widths (AP); Right: RP-RA and left: LP-LA
    • Mid-palatal arch width (RM-LM)

    Measured: T1 before starting any treatment and T2 After treatment before surgical repair (average 3 months)

  3. Angular measurement (experimental group and control group)

    The angular measurements of arch dimensions before and after treatment with the new presurgical infant orthopedic within the cleft patients in both experimental and control group.

    Angular measurements for maxillary arch assessments in degrees:

    • Vertical deviation amount of premaxilla
    • Horizontal deviation amount of premaxilla

    Measured: T1 before starting any treatment and T2 After treatment before surgical repair (average 3 months)

  4. Vertical measurement (experimental group and control group)

    The vertical measurements of arch dimensions in millimeter before and after treatment with the new presurgical infant orthopedic within the cleft patients in both experimental and control group.

    Vertical measurements for maxillary arch assessments in millimeters:

    • The height of alveolar bone at RM
    • The height of alveolar bone at LM

    Measured: T1 before starting any treatment and T2 After treatment before surgical repair (average 3 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2022
  2. Study start1 Jan 2021
  3. Primary completion15 Aug 2022
  4. Study completion1 Sep 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05535530
Sponsor's protocol ID
262421
Status last verified
Sep 2022
First submitted
4 Aug 2022
Last updated
21 Sep 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Active PSIO in people with Cleft Lip and Palate, run by University of Baghdad at 1 site in Iraq.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iraq. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Arch dimension (experimental group and control group) (time frame: T1 before starting any treatment and T2 After treatment before surgical repair (average 3 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in